ID   NCC-UPS1-X3-C1
AC   CVCL_VR16
SY   NCCUPS1X3C1
DR   DepMap; ACH-002783
DR   Wikidata; Q95992631
RX   DOI=10.11418/jtca.37.133;
WW   https://en.cellline.jp/product/ncc-ups1-x3-c1/
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Characteristics: Established from a third generation xenograft established by subcutaneous injection in female SCID mice.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo T.).
CC   Doubling time: ~40 hours (DOI=10.11418/jtca.37.133).
CC   Omics: Deep proteome analysis.
ST   Source(s): DOI=10.11418/jtca.37.133
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 12
ST   D16S539: 9,12
ST   D21S11: 28.2
ST   D5S818: 11
ST   D7S820: 11
ST   TH01: 6,7
ST   TPOX: 8
ST   vWA: 20
DI   NCIt; C4247; Undifferentiated pleomorphic sarcoma
DI   ORDO; Orphanet_2023; Undifferentiated pleomorphic sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_B3TP ! NCC-UPS1-C1
SX   Male
AG   83Y
CA   Cancer cell line
DT   Created: 13-11-18; Last updated: 30-01-24; Version: 7
//
RX   DOI=10.11418/jtca.37.133;
RA   Kito F., Oyama R., Takahashi M., Shiozawa K., Sakumoto M., Yoshida A.,
RA   Setsu N., Kobayashi E., Kawai A., Kondo T.;
RT   "Establishment and characterization of a patient-derived cancer model
RT   of undifferentiated pleomorphic sarcoma.";
RL   Tissue Cult. Res. Commun. 37:133-145(2018).
//